| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/24/2008 | CN100420746C Design and fermented production of recombinant peptide for reducing blood pressure |
| 09/23/2008 | US7427670 Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427657 Aromatic sulfenates for type 1 phototherapy |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427590 Neurothrophic components of the ADNF I complex |
| 09/23/2008 | CA2206008C Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/18/2008 | WO2008110578A2 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | WO2008048942A3 Receptor(sstr2)-selective somatostatin antagonists |
| 09/18/2008 | WO2007149948A3 Compositions and methods for diagnosis and treatment of tumors |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227701 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 09/18/2008 | US20080227700 contacting the protein with a polypeptide up to about 50 amino acids in length having molecular chaperone activity; protein conformation disease is Alexander's disease, Alzheimer's disease, Creutzfeld-Jakob disease, Parkinson's disease, Huntington's disease, cataract, retinitis pigmentosa, prion disease |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227698 oligopeptide antagonizes binding of DKK1 to LRP5 when in contact with LRP5; degenerative bone diseases |
| 09/18/2008 | US20080227693 Improved flowability and solubility with less dust and static compared to lyophilization; acid addition salt powders; ambient storage stability |
| 09/18/2008 | US20080227685 Polypeptide comprising the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125); activating guanylate cyclase C (GC-C) receptor; gastroesophageal reflux disease, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, dyspepsia, constipation |
| 09/18/2008 | US20080227205 Incorporation on Non-Naturally Encoded Amino Acids Into Proteins |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226551 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/17/2008 | EP1970379A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus |
| 09/17/2008 | EP1970064A1 Silicon-derivatives for pet-imaging |
| 09/17/2008 | EP1969000A2 Cell penetrating peptides for intracellular delivery of molecules |
| 09/17/2008 | EP1968999A2 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 09/17/2008 | EP1968995A1 Methods for the synthesis of arginine-containing peptides |
| 09/17/2008 | EP1968635A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 09/17/2008 | EP1968623A2 Bacteriocin inducer peptides |
| 09/17/2008 | EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 09/17/2008 | EP1017714B1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 09/17/2008 | CN101267829A Thrombospondin-1 derived peptides and treatment methods |
| 09/17/2008 | CN101265299A Biologically active peptides from functional domains of bactericidal permeability-increasing protein and uses thereof |
| 09/17/2008 | CN101265296A Reptile cathelicidin antibiotic peptide and derivatives, and application thereof |
| 09/17/2008 | CN101265292A Polypeptides substances, preparing method and use thereof |
| 09/17/2008 | CN101265291A Recombination pig origin antibiotic peptide PG4 and its biological synthesis method and application |
| 09/17/2008 | CN101265290A Peptide containing tryptophyl-lysyl(arginyl) fragment and anticancer use thereof |
| 09/17/2008 | CN100418980C Process for purifying glycopeptide phospohonate derivatives |
| 09/17/2008 | CN100418574C chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene |
| 09/16/2008 | US7425608 Combinatorial library of different sequence peptide members synthesized on solid phase, where each constituent library member includes peptide sequence of three or more amino acid residues bound to solid phase characterized by sequence of two or more amino acid residues forming a metal ion-binding domain |
| 09/16/2008 | US7425541 Therapy of tumors; prodrugs that display a high specificity of action, a reduced toxicity, and an improved stability in blood |
| 09/16/2008 | US7425540 Method for modification of NMDA receptors through inhibition of Src |
| 09/16/2008 | US7425425 Method for the detection of enzyme-catalyzed cleavage reactions by fluorescence spectroscopy |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425335 Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/16/2008 | CA2110730C Sustained-release preparation |
| 09/16/2008 | CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/12/2008 | WO2008109653A2 Peptides specific for human blood outgrowth endothelial cells |
| 09/12/2008 | WO2008108941A2 Integrated photoactive peptides and uses thereof |
| 09/12/2008 | WO2008108668A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/12/2008 | WO2008108505A1 Novel nuclear translocation peptide |
| 09/12/2008 | WO2008108285A1 Peptide |
| 09/12/2008 | WO2008108242A1 Brain-migrating polypeptide having polyvalent bond and improved metabolic stability |
| 09/12/2008 | WO2008107448A2 Process for the manufacture of a composite material |
| 09/12/2008 | WO2008107362A2 Stabiliser and inhibitors of factor vii |
| 09/12/2008 | WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 09/12/2008 | WO2008042421A3 Peptides derived from the c2 domain of epsilon pkc, and use thereof |
| 09/12/2008 | CA2680196A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/12/2008 | CA2675195A1 Process for the manufacture of a composite material |
| 09/11/2008 | US20080221304 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents |
| 09/11/2008 | US20080221041 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 09/11/2008 | US20080221040 Compositions and Methods for the Control of Mammary Cell Number |
| 09/11/2008 | US20080221039 Kinin Antagonists For Treating Bladder Dysfunction |
| 09/11/2008 | US20080221038 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders |
| 09/11/2008 | US20080221028 Compositions and Methods for Treating Atherosclerosis |
| 09/11/2008 | US20080220459 Using presence of collagen IX alpha-1chain polypeptide fragments as diagnostic indicator of arthritic, bone, cardiovascular and/or inflammatory disorders |
| 09/11/2008 | US20080220409 Lymphocyte epitope for use as evaluative tool in diagnosis of flaviviral infection |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219947 Single chain trimers and uses therefor |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967582A1 Material for cell culture |
| 09/10/2008 | EP1967524A1 Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby |
| 09/10/2008 | EP1966389A1 Enzyme measurement assay using a modified substrate comprising a substrate attached to a macromolecule via a spacer |
| 09/10/2008 | EP1966234A2 Endometriosis cell targeting peptides and uses thereof |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | CN101262844A Method for enhancing the effect of particulate benefit agents |
| 09/10/2008 | CN101260147A Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 09/09/2008 | US7423116 Pentapeptide compounds and uses related thereto |
| 09/09/2008 | US7423115 Inducing an apoptosis or a killing of a cell, enhancing an effectiveness of cancer chemotherapy |
| 09/09/2008 | US7423114 GD2 ligands |
| 09/09/2008 | US7423021 Peptidic thrombin inhibitors |
| 09/09/2008 | US7423017 Method for treating cartilage disorders |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422867 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2546625C Glycopeptide antibiotic derivatives |
| 09/09/2008 | CA2251842C Small molecule mimetics of erythropoietin |